Meet the Pfizer Executive Leadership Team: John Young John Young is President and General Manager of Pfizer’s Primary Care Business Unit and a member of Pfizer’s Executive Leadership Team. Prior to his appointment he was the Primary Care Business Unit’s Regional President for Europe and Canada, a position he held since 2009. John has deep […]
Meet the Pfizer Executive Leadership Team: Amy W. Schulman Amy W. Schulman is an innovative, results-focused leader and a champion for diversity and women’s professional advancement. Since 2008 she has led the Pfizer Legal Division, which handles some of the most complex, challenging legal matters within a highly regulated industry. Ms. Schulman also leads Pfizer’s […]
Meet the Pfizer Executive Leadership Team: Anthony J. Maddaluna Anthony J. Maddaluna was named President in January 2011. Prior to that time, he was Senior Vice President, PGM Strategy and Supply Network Transformation, with overall responsibility for PGM’s supply network transformation strategy. Under Tony’s leadership in that position, PGM focused on plant network strategy, capturing […]
Meet the Pfizer Executive Leadership Team: Doug Lankler Doug Lankler is Executive Vice President, Chief Compliance & Risk Officer. He has overall responsibility for the Company’s corporate compliance programs and reports to the Chief Executive Officer. Doug has been with Pfizer since 1999. He has been the Chief Compliance & Risk Officer since 2006. Prior […]
Meet the Pfizer Executive Leadership Team: Geno Germano Geno Germano is President and General Manager of Specialty Care and Oncology, Pfizer Inc. The Specialty Care Business Unit (SCBU) works closely with specialty physicians and stakeholders to provide medicines to help treat a variety of serious and life-threatening conditions. Specialty Care holds leadership positions in vaccines […]
Meet the Pfizer Executive Leadership Team: Frank D’ Amelio Frank D’Amelio is the Executive Vice President, Business Operations & Chief Financial Officer of Pfizer, responsible for finance, business development and business operations, including IT, procurement and real estate. Before joining the company in September 2007, he was Senior Executive Vice President of Integration and Chief […]
Meet the Pfizer Executive Leadership Team: Olivier Brandicourt Olivier Brandicourt, M.D., is President and General Manager of the Emerging Markets and Established Products Business Units. He has 25 years of international experience in the pharmaceutical industry including executive responsibilities in France, the United States, Canada and the United Kingdom. He has held senior operational positions […]
Pfizer Pipeline: New Drugs In The Making (August 9, 2013) – Pfizer is in the process of developing the following new drugs that may prove very useful in the field of Psychiatry drugs: AAC-001 (Phase 2): New Alzheimer’s disease vaccine AAB-003 (Phase 1): New biologic Alzheimer’s treatment SAM-760 (Phase 3): New Alzheimer’s treatment PF-04958242 (Phase […]
Is San Diego Ready for an Aging Population? New Local Survey Reveals San Diego-Area Residents Concerned about Their City and Themselves as They Get Old; New Website, “By the Decades” Healthy Aging Checklist and Aging Communities Toolkit Offers Help NEW YORK–(July 11, 2013)–More than eight out of ten people who live in the San Diego […]
Pfizer Accolades 2013 June QUESTAR Award – The International Awards Festival for Excellence in Video Communications Pfizer was awarded the Grand — best of category — in Annual Reports in the 2013 Questar Awards. Telly Award – For over a quarter century, the Telly statuette has been a symbol of creative excellence. Pfizer was awarded […]